Page 28 - NATIONAL ANTIBIOTIC RESISTANCE SURVEILLANCE REPORT 2021

Acinetobacter baumannii from all clinical specimens

Table 7: Percentage of antibiotic resistance for Acinetobacter baumannii isolated from all samples.

The number of samples tested is stated in a bracket.

Antibiotic 2017 2018 2019 2020 2021
%R (no. tested) %R (no. tested) %R (no. tested) %R (no. tested) %R (no. tested)

49.8 (8155) 31.5 (7348) 44.3 (7495) 48.5 (6463) 57.5 (9540)
Amikacin

57.1 (7627) 56.0 (7272) 51.5 (7642) 53.6 (6311) 63.8 (9530)
Ampicillin/sulbactam

Cefoperazone/ 46.8 (5655) 48.6 (5369) 33.0 (4860) 29.6 (4479) 42.4 (6825)
sulbactam

Ceftazidime 58 (8183) 37.9 (7377) 52.2 (7337) 56.8 (6336) 67.5 (9717)

Gentamicin 53.2 (7860) 33.3 (7202) 47.7 (7513) 52.5 (6147) 60.8 (9025)

Imipenem 61.7 (7795) 41.3 (7261) 54.4 (7552) 58.1 (6435) 67.7 (9428)

Meropenem 61.1 (7964) 41.1 (7215) 55.5 (7468) 58.7 (6377) 68.8 (9432)

25 |